Skip to content

Optimus Drugs – Walk-In Drive for Microbiology / PD Lab / Engineering Department on 25th & 26th July’ 2025

Optimus Drugs Pvt. Ltd (Sekhmet Pharma) was established in the year 2004 as custom synthesis laboratory by a team of Technocrats. It is one of the fastest growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. We expanded into global markets and started filing DMFs for both APIs and Intermediates with various Regulatory agencies. Optimus Research Center for API & Formulations was set-up as a centralized Research and Development center to focus on Generic product developments suitable for regulated markets.

 

Walk-In Interview conducting for Microbiology, PD Lab, Engineering positions (Fitter & Water System) at Optimus Drugs Pvt. Ltd, Unit-1, Dothigudem, a leading USFDA-approved pharmaceutical company.

Job Details:
  • Positions: Executive
  • Department: Microbiology
  • Qualifications: B.Sc / M.Sc
  • Experience: 1 to 6 years.

 

Walk-in Interview Details:

  • Date : July 25, 2025 (Saturday)
  • Timings:  09:30 to 12:00 hrs.
  • Venue: Survey No. 239 & 240, Dothigudem (Vi), Pochampally (M), Yadadri Bhuvanagiri (D)-508284, Telangana, India.

 

Application Process: Candidates unable to attend can share their updated CVs to [email protected] or [email protected].

 

Job Details:
  • Positions: Trainees, Executive
  • Department: PD Lab / Engineering (Fitter & Water System).
  • Qualifications: B.Sc / M.Sc / ITI/Diploma (Mechanical).
  • Experience: 0 to 5 years.

 

Walk-in Interview Details:

  • Date : 25th & 26th July, 2025 (Friday & Saturday)
  • Timings:  09:30 to 12:00 hrs.
  • Venue: Survey No. 239 & 240, Dothigudem (Vi), Pochampally (M), Yadadri Bhuvanagiri (D)-508284, Telangana, India.

 

Requirements for Interview: Updated CV, latest CTC details, last three months’ pay slips, and relevant documents.

Note: Candidates with a pharma background are preferred for immediate joining or early joining, and all necessary precautions (like wearing a mask) should be followed.